An open label trial of telbivudine (LdT) in adults with chronic hepatitis B previously treated in Idenix-sponsored telbivudine studies
Latest Information Update: 06 May 2022
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 22 Jul 2011 Actual initiation date (Mar 2005) added as reported by ClinicalTrials.gov.
- 22 Jul 2011 Additional trial locations identified as reported by ClinicalTrials.gov.
- 21 Dec 2007 Added trial location and trial centres.